LAVAL, QC, Aug. 15, 2018 /CNW Telbec/ - Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT), announces the voting results for the matters listed in its management proxy circular dated July 17, 2018 held at its Annual and Special Meeting of Shareholders in Montreal, Canada on August 15, 2018 (the "AGM").
Election of Directors. According to proxies received and a vote by show of hands, the following individuals were elected as directors of Neptune for the ensuing year.
| Nominee |
Votes For |
% Votes For |
Votes Withheld |
% Votes Withheld |
| John M. Moretz |
25,578,652 |
95.93% |
1,084,928 |
4.07% |
| Katherine Crewe |
25,606,234 |
96.03% |
1,057,346 |
3.97% |
| Ronald Denis |
25,944,136 |
97.30% |
719,444 |
2.70% |
| Richard Schottenfeld |
25,948,860 |
97.32% |
714,720 |
2.68% |
| James S. Hamilton |
25,659,402 |
96.23% |
1,004,178 |
3.77% |
Appointment of Auditors. According to proxies received and a vote by show of hands, KPMG LLP were appointed as the Corporation's auditors for the ensuing fiscal year and the directors were authorized to fix their remuneration.
| KPMG LLP |
Votes in Favor |
% In Favor |
Votes Withheld |
% Withheld |
| 52,970,259 |
99.77% |
122,716 |
0.23% |
Approval of Stock Option Plan Renewal. According to proxies received and a vote by show of hands, the unallocated options under the Corporation's stock option plan were approved.
| Stock Option Plan Renewal |
Votes in Favor |
% In Favor |
Votes Against |
% Against |
| 24,143,393 |
90.55% |
2,520,187 |
9.45% |
Approval of Amended Stock Option Plan. According to proxies received and a vote by show of hands, a majority of disinterested shareholders1 approved the Corporation's amended stock option plan.
| Stock Option Plan Amendment |
Votes in Favor |
% In Favor |
Votes Against |
% Against |
| 16,748,124 |
86.22% |
2,677,471 |
13.78% |
Approval of Stock Option Grants. According to proxies received and a vote by show of hands, a majority of disinterested shareholders2 approved the grant of 2,095,333 options to purchase common shares of the Corporation to certain executives and Board members.
| Stock Option Grants Ratification |
Votes in Favor |
% In Favor |
Votes Against |
% Against |
| 16,816,511 |
86.57% |
2,609,084 |
13.43% |
Approval of Equity Incentive Plan Renewal. According to proxies received and a vote by show of hands, the unallocated entitlements under the Corporation's equity incentive plan were approved.
| Equity Incentive Plan Renewal |
Votes in Favor |
% In Favor |
Votes Against |
% Against |
| 24,195,403 |
90.74% |
2,468,177 |
9.26% |
Approval of Amended Equity Incentive Plan. According to proxies received and a vote by show of hands, a majority of disinterested shareholders3 approved the Corporation's amended equity incentive plan.
| Equity Incentive Plan Amendments |
Votes in Favor |
% In Favor |
Votes Against |
% Against |
| 16,806,368 |
86.52% |
2,619,227 |
13.48% |
Approval of Name Change. According to proxies received and a vote by show of hands, the change of name of the Corporation from "Neptune Technologies & Bioressources Inc." to "Neptune Wellness Solutions Inc." / "Neptune Solutions Bien-être Inc." was approved by at least two thirds of the votes cast by shareholders at the meeting.
| Name Change Approval |
Votes in Favor |
% In Favor |
Votes Against |
% Against |
| 50,390,243 |
94.91% |
2,702,731 |
5.09% |
For further information on the voting results of the resolution passed during the AGM, please refer to the Report of Voting Results available on SEDAR.
About Neptune Technologies & Bioressources Inc.
Neptune is a health and wellness products company, with more than 50 years of combined experience in extraction, purification and formulation of value-added differentiated science-based products. Currently, the Company develops turnkey nutrition product solutions available in various unique delivery forms, offers specialty ingredients such as MaxSimil®, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and a variety of other marine and seed oils. Leveraging its scientific, technological and innovative expertise, Neptune is preparing to commence production of products in legal cannabis markets.
The Company's head office is located in Laval, Quebec.
| ___________________________ |
|
| 1 |
Excluding the votes of insiders to whom stock options may be granted under the stock option plan and their associates, representing a total of 7,237,985 votes. |
| 2 |
Excluding the votes of the recipients of the granted options, and insiders to whom stock options may be granted under the stock option plan and their associates, representing a total of 7,237,985 votes. |
| 3 |
Excluding the votes of insiders to whom entitlements may be granted under the equity incentive plan and their associates, representing a total of 7,237,985 votes. |
SOURCE Neptune Technologies & Bioresources inc.
Neptune Wellness Solutions, Mario Paradis, VP & CFO, Neptune, 1.450.687.2262 x236, [email protected]; Investor Relations Contact (Canada), Pierre Boucher, MaisonBrison, 1.514.731.0000, [email protected]; Investor Relations Contact (U.S.), Jody Burfening, LHA, 1.212.838.3777, [email protected]
Share this article